Richard Glickman

Richard M.
Glickman was the founder of Aurinia Pharmaceuticals, Inc., founded in 1993, where the title held was Chairman & Chief Executive Officer from 2013 to 2019.
Dr. Glickman was the founder of Aspreva Pharmaceuticals Corp., founded in 2001, where the title held was Chairman & Chief Executive Officer from 2001 to 2006.
Dr. Glickman was also the founder of Probtec Corp.,Nventa Biopharmaceuticals Corp.,Stressgen Biotechnologies Corp.,Ontario Molecular Diagnostics,Aurinia Pharmaceuticals, Inc.,Aurinia Pharma Corp...
Dr. Glickman was previously a Director at MedGenesis Therapeutix, Inc. Dr. Glickman is a Director at enGene, Inc. since 2011.
Dr. Glickman is an Independent Director at Eupraxia Pharmaceuticals, Inc. since 2021.
Dr. Glickman is a Director at Vida Pharmaceuticals Pvt Ltd. Dr. Glickman is a Director at Eurpraxia Pharmaceuticals, Inc. Dr. Glickman is a Venture Partner at Lumira Capital Investment Management, Inc. Former positions include Chairman at Vigil Health Solutions, Inc. and LifeSciences British Columbia.
Chairman at ESSA Pharma, Inc. from 2010 to 2025.
Chairman at enGene Therapeutics, Inc. from 2024 to 2026.
Lead Independent Director at Correvio Pharma Corp.
Director at Canadian Genetic Disease Network, Vancouver Aquarium, and viDA Therapeutics, Inc. Member at Innovate BC.
Venture Partner at Kearny Venture Partners.